Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | RXRA | P19793 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.38 |
| ▸ | F7 | P08709 | 3/20 | 0.38 |
| ▸ | F3 | P13726 | 3/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11853506 | 1.00 | ALDH1A1 (0.40) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL11853510 | 1.00 | ALDH1A1 (0.40) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL6065110 | 0.84 | FAAH (0.48) | CYP19A1PPARGMAPTCES2CES1 | |
| SCHEMBL6065108 | 0.84 | FAAH (0.48) | CYP19A1PPARGMAPTCES2CES1 | |
| SCHEMBL11806490 | 0.84 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL11533285 | 0.82 | — | — | |
| SCHEMBL11533281 | 0.82 | — | — | |
| SCHEMBL11078516 | 0.79 | — | — | |
| SCHEMBL16705751 | 0.79 | — | — | |
| SCHEMBL9327903 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170335355-A1 | METHOD FOR PRODUCING OXO FATTY ACID AND RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-11-23 | — | — | US | disclosed |
| US-9719115-B2 | Method for producing oxo fatty acid and rare fatty acid | KYOTO UNIVERSITY (JP) | 2017-08-01 | — | — | US | disclosed |
| US-9707200-B2 | Metabolism-improving agent comprising rare fatty acid | KYOTO UNIVERSITY (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9539229-B2 | Intestinal tract-protecting agent containing hydroxylated fatty acid | KYOTO UNIVERSITY (JP) | 2017-01-10 | — | — | US | disclosed |
| US-20160000739-A1 | INTESTINAL TRACT-PROTECTING AGENT CONTAINING HYDROXYLATED FATTY ACID | NOSTER INC. (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20150342916-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | NOSTER INC. (JP) | 2015-12-03 | — | — | US | disclosed |
| US-20150125911-A1 | METHOD FOR PRODUCING OXO FATTY ACID AND RARE FATTY ACID | NOSTER INC. (JP) | 2015-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150342916-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | FADS1, FASN, ELOVL1 | ALDH1A1 757/4885CYP19A1 369/4885PPARG 147/4885 |
| US-20160000739-A1 | INTESTINAL TRACT-PROTECTING AGENT CONTAINING HYDROXYLATED FATTY ACID | FABP2, SI, VIP | ALDH1A1 331/4885CYP19A1 778/4885PPARG 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.